BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28108300)

  • 1. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis.
    Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B
    J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
    Zhang Y; Cheng C; Wang S; Xu M; Zhang D; Zeng W
    Life Sci; 2019 Sep; 232():116637. PubMed ID: 31288014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway.
    Nagar H; Kim S; Lee I; Kim S; Choi SJ; Piao S; Jeon BH; Oh SH; Kim CS
    Sci Rep; 2021 Jan; 11(1):500. PubMed ID: 33436666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DKK3 regulates cell proliferation, apoptosis and collagen synthesis in keloid fibroblasts via TGF-β1/Smad signaling pathway.
    Li Y; Liu H; Liang Y; Peng P; Ma X; Zhang X
    Biomed Pharmacother; 2017 Jul; 91():174-180. PubMed ID: 28458155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS; Wu PH; Fang AH; Lan CC
    Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-21 Regulates Keloid Formation by Downregulating Smad7 via the TGF-β/Smad Signaling Pathway.
    Wu J; Fang L; Cen Y; Qing Y; Chen J; Li Z
    J Burn Care Res; 2019 Oct; 40(6):809-817. PubMed ID: 31184708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
    Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells.
    Jiang L; Lai YK; Zhang JF; Chan CY; Lu G; Lin MC; He ML; Li JC; Kung HF
    World J Gastroenterol; 2012 May; 18(17):2035-42. PubMed ID: 22563190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
    Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
    Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
    Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
    He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
    Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
    Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
    J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the methylation enzyme inhibitors of 5-aza-2-deoxycytidine on the TGF-beta/smad signal transduction pathway in human keloid fibroblasts].
    Zou QP; Yang E; Zhang HS
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jul; 29(4):285-9. PubMed ID: 24228511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA.
    Gao Z; Wang Z; Shi Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhao Y; Wu H; Jin Y
    Plast Reconstr Surg; 2006 Nov; 118(6):1328-1337. PubMed ID: 17051103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
    Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T
    Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxymatrine inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Fan DL; Zhao WJ; Wang YX; Han SY; Guo S
    Int J Dermatol; 2012 Apr; 51(4):463-72. PubMed ID: 22435440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SnoN co-repressor binds and represses smad7 gene promoter.
    Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
    Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma.
    Nakahata S; Yamazaki S; Nakauchi H; Morishita K
    Oncogene; 2010 Jul; 29(29):4157-69. PubMed ID: 20514018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids.
    Cho JW; Il KJ; Lee KS
    Int J Mol Med; 2013 May; 31(5):1148-52. PubMed ID: 23503720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.